| 专利名称 | Bladder cancer tumor marker, antibody and use thereof | 申请号 | US201113814446 | 专利类型 | US | 公开（公告）号 | US9073995(B2) | 公开（授权）日 | 2015.07.07 | 申请（专利权）人 | 中国科学院生物物理研究所 | 发明（设计）人 | Li Chong;Fan Zusen;Zhang Honglian;Dai Zhonghua;Tang Haidong;Chen Jun | 主分类号 | G01N33/53 | IPC主分类号 | G01N33/53;C07K16/00;C07K16/28;C07K14/705;G01N33/574;G01N33/68;C12N15/113;C12Q1/48;C12Q1/02;A61K47/48;A61K51/10;A61K45/06;A61K39/395;C07K16/30;C12N9/10 | 专利有效期 | Bladder cancer tumor marker, antibody and use thereof 至Bladder cancer tumor marker, antibody and use thereof | 法律状态 | 说明书摘要 | Provided in the present invention are an aberrantly glycosylated integrin, AG-α3β1, and use thereof as a bladder cancer marker. Also provided in the present invention are a hybridoma cell generating an anti-AG-α3β1 monoclonal antibody, a monoclonal antibody BCMab1 secreted by the same, and use of BCMab1 in the preparation of a medicament for the treatment of bladder cancer. Also provided in the present invention is use of inhibitors of GAL3ST2 and N-acetylgalactosaminyltransferase 1 in the preparation of a medicament for the treatment of bladder cancer. |
1、源头对接，价格透明
2、平台验证，实名审核
3、合同监控，代办手续
4、专员跟进，交易保障